AbCellera Biologics (ABCL) Q1 2026 Earnings

Feb 24Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.19
-0.14
-0.08
-0.03

Details

Expected EPS
-0.134
Actual EPS
-0.03
Surprise EPS
0.1
Surprise Percent
+77.61%

Description

⁨AbCellera Biologics⁩ (⁦ABCL⁩) has reported earnings of ⁦-0.03⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts